探花合集 to Launch OneBio鈩 Suite for Integrated Biologics Development, Manufacturing and Supply at BIO International 2019
OneBio has been designed specifically to address the challenges facing biologic development companies that are looking to accelerate programs to clinic or market, or that require greater simplicity in the development process, including fewer internal resource needs and a reduced risk of rework. As a single, integrated provider, 探花合集 Biologics鈥 OneBio Suite will aim to reduce timelines, risk and complexity by providing customers with a single contract, program manager, and development timeline from cell line to clinical supply with harmonized quality systems. The OneBio Suite draws upon 探花合集鈥檚 proven track record of progressing biologic drugs to market, which includes over 115 global clinical trials and 11 commercially marketed monoclonal antibodies using the company鈥檚 GPEx庐聽cell line development technology, and 20 approved products through fill/finish and commercial supply to global markets.
鈥淭ime is often lost for sponsors on the path to clinic from contract negotiation, site inspections, handoffs, and poor communication between multiple vendors,鈥 commented Bernie Clark, Vice President, Marketing & Strategy, 探花合集 Biologics & Specialty Drug Delivery. 鈥淭hrough our new OneBio Suite, 探花合集 is uniquely positioned to provide an integrated offering that can accelerate biologic development potentially shaving weeks to months off standard timelines and allowing our customers to get to clinic and market faster.鈥
Additionally, at the BIO Convention, Steven Hager, Ph.D., Senior Director, Technical Support, will present 鈥楥ell Line Development Strategies for Difficult to Express Proteins鈥 as part of the 鈥楨merging Techniques, Technologies and Strategies鈥 track. His presentation takes place on Wednesday, June 5 from 11:40 a.m.-12:00 p.m. at the BPI Theater, Booth #3211 in the BioProcess Zone.
On the same day, from 1:45 鈥 2:30 p.m., Dr. Hager will also participate in a 鈥楽ingle Use Systems Versus Stainless Steel鈥 roundtable, also at the BPI Theater.
探花合集 Biologics provides advanced technologies and integrated solutions for biologic and biosimilar development and manufacturing, from DNA to fill/finish and commercial supply, through its extensive Biologics network including: Bloomington, Indiana, where the company recently announced a twentieth commercial launch of a fill/finish product, and; Madison, Wisconsin, home of 探花合集 Biologics鈥 proprietary GPEx technology for stable, high-yielding mammalian cell lines with eleven approved molecules. For more information on 探花合集 Biologics, visit聽.
Media Contacts:
Chris Halling
+44 (0)7580 041073
[email protected]
Richard Kerns
+44 (0) 161 728 5880
[email protected]
ABOUT CATALENT BIOLOGICS
探花合集 Biologics has 20+ years鈥 experience in development, manufacturing, and analytical services for new biological entities, biosimilars, and antibody-drug conjugates. 探花合集 has worked with 600+ mAbs and 80+ proteins, and more than 115 clinical trials and 11 marketed products have used GPEx庐聽cell line engineering technology. A further 20 commercially-approved products have employed 探花合集 Biologics鈥 capabilities through to aseptic fill/finish. Using advanced protein improvement technology and tailored solutions from DNA through to clinical and commercial supply, 探花合集 Biologics brings better biologic treatments to patients, faster. For more information, visit聽
ABOUT CATALENT
探花合集 is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 85 years serving the industry, 探花合集 has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. 探花合集 employs over 11,000 people, including over 1,800 scientists, at more than 30 facilities across five continents, and in fiscal year 2018 generated approximately $2.5 billion in annual revenue. 探花合集 is headquartered in Somerset, New Jersey. For more information, visit聽www.catalent.com
More products. Better treatments. Reliably supplied.鈩